首页 > 最新文献

Brazilian Journal of Otorhinolaryngology最新文献

英文 中文
Metabolic biomarkers mediate allergic rhinitis via circulating inflammatory proteins: Evidence from a Mendelian randomization study 代谢生物标志物通过循环炎症蛋白介导过敏性鼻炎:来自孟德尔随机研究的证据
IF 1.7 4区 医学 Q2 OTORHINOLARYNGOLOGY Pub Date : 2025-09-01 Epub Date: 2025-06-25 DOI: 10.1016/j.bjorl.2025.101658
Xiang Cao , Boyang Zhang , Wei Wang , Zijiao Xu , Zhixin Jiang

Objective

Allergic Rhinitis (AR), a prevalent allergic condition, markedly diminishes quality of life and increases public health burdens. This study investigated the mediating roles of Metabolic Biomarkers (MBs) in the associations between Circulating Inflammatory Proteins (CIPs) and AR, aiming to uncover novel therapeutic targets.

Methods

Utilizing Mendelian Randomization (MR), we leveraged genetic variants as instrumental variables to delineate causal relationships between CIPs and AR. Data were extracted from comprehensive Genome-Wide Association Studies (GWAS). A two-sample MR approach was employed to assess both the direct and mediated effects of CIPs on AR through MBs. Inverse-Variance Weighting (IVW) served as the main analytical method, supplemented by rigorous sensitivity analyses to confirm the robustness of the findings.

Results

Our analysis revealed that specific CIPs like C-C motif Chemokine-19 (CCL19), Notch-like Epidermal growth factor-related Receptor (DNER), and Interleukin-6 (IL-6) significantly elevate the risk of AR, whereas Interleukin-10 (IL-10) exhibit protective properties. Key MBs, notably Adenosine 5'-Monophosphate (AMP) to urate ratio, plasma lactate, and N-acetylputrescine, played critical roles in mediating these relationships, indicating their potential as therapeutic targets.

Conclusion

This investigation highlights the pivotal role of MBs in modulating the influence of CIPs on AR. The insights gained from this study not only deepen our understanding of AR pathophysiology but also open new avenues for metabolic intervention in its treatment.

Level of evidence

In terms of level of evidence, MR studies are second only to randomized controlled trials.
目的变应性鼻炎(allergic Rhinitis, AR)是一种常见的过敏性疾病,显著降低了患者的生活质量,增加了公共卫生负担。本研究探讨了代谢生物标志物(mb)在循环炎症蛋白(cip)和AR之间的关联中的介导作用,旨在发现新的治疗靶点。方法利用孟德尔随机化(MR),利用遗传变异作为工具变量来描述cip和AR之间的因果关系。数据来自全面的全基因组关联研究(GWAS)。采用双样本MR方法评估cip通过MBs对AR的直接和介导作用。反方差加权(IVW)是主要的分析方法,辅以严格的敏感性分析来确认研究结果的稳健性。结果C-C基序趋化因子-19 (CCL19)、缺口样表皮生长因子相关受体(DNER)和白细胞介素-6 (IL-6)等特异性cip可显著提高AR的风险,而白细胞介素-10 (IL-10)则具有保护作用。关键的MBs,特别是腺苷5′-单磷酸腺苷(AMP)与尿酸比率、血浆乳酸和n -乙酰腐胺,在介导这些关系中发挥了关键作用,表明它们作为治疗靶点的潜力。结论本研究强调了MBs在调节cip对AR的影响中的关键作用。本研究的见解不仅加深了我们对AR病理生理的理解,而且为代谢干预治疗AR开辟了新的途径。证据水平就证据水平而言,磁共振研究仅次于随机对照试验。
{"title":"Metabolic biomarkers mediate allergic rhinitis via circulating inflammatory proteins: Evidence from a Mendelian randomization study","authors":"Xiang Cao ,&nbsp;Boyang Zhang ,&nbsp;Wei Wang ,&nbsp;Zijiao Xu ,&nbsp;Zhixin Jiang","doi":"10.1016/j.bjorl.2025.101658","DOIUrl":"10.1016/j.bjorl.2025.101658","url":null,"abstract":"<div><h3>Objective</h3><div>Allergic Rhinitis (AR), a prevalent allergic condition, markedly diminishes quality of life and increases public health burdens. This study investigated the mediating roles of Metabolic Biomarkers (MBs) in the associations between Circulating Inflammatory Proteins (CIPs) and AR, aiming to uncover novel therapeutic targets.</div></div><div><h3>Methods</h3><div>Utilizing Mendelian Randomization (MR), we leveraged genetic variants as instrumental variables to delineate causal relationships between CIPs and AR. Data were extracted from comprehensive Genome-Wide Association Studies (GWAS). A two-sample MR approach was employed to assess both the direct and mediated effects of CIPs on AR through MBs. Inverse-Variance Weighting (IVW) served as the main analytical method, supplemented by rigorous sensitivity analyses to confirm the robustness of the findings.</div></div><div><h3>Results</h3><div>Our analysis revealed that specific CIPs like C-C motif Chemokine-19 (CCL19), Notch-like Epidermal growth factor-related Receptor (DNER), and Interleukin-6 (IL-6) significantly elevate the risk of AR, whereas Interleukin-10 (IL-10) exhibit protective properties. Key MBs, notably Adenosine 5'-Monophosphate (AMP) to urate ratio, plasma lactate, and N-acetylputrescine, played critical roles in mediating these relationships, indicating their potential as therapeutic targets.</div></div><div><h3>Conclusion</h3><div>This investigation highlights the pivotal role of MBs in modulating the influence of CIPs on AR. The insights gained from this study not only deepen our understanding of AR pathophysiology but also open new avenues for metabolic intervention in its treatment.</div></div><div><h3>Level of evidence</h3><div>In terms of level of evidence, MR studies are second only to randomized controlled trials.</div></div>","PeriodicalId":49099,"journal":{"name":"Brazilian Journal of Otorhinolaryngology","volume":"91 5","pages":"Article 101658"},"PeriodicalIF":1.7,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144472321","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Predictive factors for outcomes of sialoendoscopy 涎内镜检查结果的预测因素
IF 1.7 4区 医学 Q2 OTORHINOLARYNGOLOGY Pub Date : 2025-09-01 Epub Date: 2025-05-14 DOI: 10.1016/j.bjorl.2025.101631
Hannah Damasceno Barreto , Jose Higino Steck , Samuel Serpa Steck , Diogo Silva de Carvalho , Carlos Takahiro Chone

Objectives

We evaluated the epidemiological and clinical factors related to the complications and failure of sialoendoscopy.

Methods

This retrospective study analyzed the medical records of patients who underwent sialoendoscopy between 2010 and 2019.

Results

Of the 174 sialoendoscopies analyzed, 125 (71.8%) were performed in women, and 114 (65.5%), in the parotid gland. The most prevalent complications described were false path (4.59%) and restenosis (2.30%). Complications in the submandibular gland were 3.43 times more common than those in the parotid gland and procedures in that gland were less successful (86.7% vs. 91.2%). Sialolithiasis treatment was most strongly associated with complications and failure then the other groups.

Conclusion

Sialoendoscopy has uncommon and limited complications. Procedures in the submandibular gland and for sialolithiasis treatment were more likely to result in complications and recurrences.

Level of evidence

4.
目的探讨涎腺内镜手术并发症及失败的流行病学及临床因素。方法回顾性分析2010年至2019年接受口腔内镜检查患者的病历。结果174例涎腺内窥镜检查中,女性125例(71.8%),腮腺114例(65.5%)。最常见的并发症是假径(4.59%)和再狭窄(2.30%)。颌下腺的并发症是腮腺的3.43倍,腮腺的手术成功率较低(86.7%比91.2%)。与其他组相比,涎石症治疗与并发症和失败的关系最为密切。结论涎腔内窥镜检查并发症少见,并发症有限。治疗颌下腺和涎石症的手术更容易导致并发症和复发。证据水平4。
{"title":"Predictive factors for outcomes of sialoendoscopy","authors":"Hannah Damasceno Barreto ,&nbsp;Jose Higino Steck ,&nbsp;Samuel Serpa Steck ,&nbsp;Diogo Silva de Carvalho ,&nbsp;Carlos Takahiro Chone","doi":"10.1016/j.bjorl.2025.101631","DOIUrl":"10.1016/j.bjorl.2025.101631","url":null,"abstract":"<div><h3>Objectives</h3><div>We evaluated the epidemiological and clinical factors related to the complications and failure of sialoendoscopy.</div></div><div><h3>Methods</h3><div>This retrospective study analyzed the medical records of patients who underwent sialoendoscopy between 2010 and 2019.</div></div><div><h3>Results</h3><div>Of the 174 sialoendoscopies analyzed, 125 (71.8%) were performed in women, and 114 (65.5%), in the parotid gland. The most prevalent complications described were false path (4.59%) and restenosis (2.30%). Complications in the submandibular gland were 3.43 times more common than those in the parotid gland and procedures in that gland were less successful (86.7% vs. 91.2%). Sialolithiasis treatment was most strongly associated with complications and failure then the other groups.</div></div><div><h3>Conclusion</h3><div>Sialoendoscopy has uncommon and limited complications. Procedures in the submandibular gland and for sialolithiasis treatment were more likely to result in complications and recurrences.</div></div><div><h3>Level of evidence</h3><div>4.</div></div>","PeriodicalId":49099,"journal":{"name":"Brazilian Journal of Otorhinolaryngology","volume":"91 5","pages":"Article 101631"},"PeriodicalIF":1.7,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143947913","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Disulfidptosis ‒ related lncRNAs are biomarkers of prognosis and immune response in Head and Neck Squamous Cell Carcinoma 与双垂相关的lncrna是头颈部鳞状细胞癌预后和免疫反应的生物标志物
IF 1.7 4区 医学 Q2 OTORHINOLARYNGOLOGY Pub Date : 2025-09-01 Epub Date: 2025-05-15 DOI: 10.1016/j.bjorl.2025.101625
Ruilin Wang , Qi Zhang , Yuxiu Ma , Xuelin Liu , Tian Lan , Hongling Li

Objective

This study aims to explore the role of Disulfidptosis-Related long Non-Coding RNAs (DRlncRNAs) in the prognosis and immune infiltration of Head and Neck Squamous Cell Carcinoma (HNSCC).

Methods

Using bioinformatics approaches, this study investigates the prognostic significance of DRlncRNAs in HNSCC patients and their potential association with the immune microenvironment. RNA sequencing data and clinical information for HNSCC were obtained from The Cancer Genome Atlas (TCGA) database. DRlncRNAs were identified through Pearson correlation analysis, and a prognostic model consisting of six DRlncRNAs was constructed using Least Absolute Shrinkage and Selection Operator (LASSO) regression, along with univariate and multivariate Cox analyses.

Results

The predictive performance of the model was assessed using Receiver Operating Characteristic (ROC) curves and Principal Component Analysis (PCA), and further validated using calibration curves, a nomogram, and univariate/multivariate Cox analyses. In addition to functional enrichment analysis, the associations between the model and Tumor Mutation Burden (TMB), immune cell infiltration, and drug sensitivity were also examined.

Conclusion

We developed a novel predictive model composed of six DRlncRNAs to predict the prognosis of HNSCC patients and proposed potential clinical therapeutic targets from the perspective of disulfidptosis.

Level of evidence

Level 5.
目的探讨二硫分解相关长链非编码rna (DRlncRNAs)在头颈部鳞状细胞癌(HNSCC)预后和免疫浸润中的作用。方法采用生物信息学方法,探讨drlncrna在HNSCC患者中的预后意义及其与免疫微环境的潜在关联。HNSCC的RNA测序数据和临床信息来自癌症基因组图谱(TCGA)数据库。通过Pearson相关分析确定DRlncRNAs,并使用最小绝对收缩和选择算子(LASSO)回归以及单因素和多因素Cox分析构建由6个DRlncRNAs组成的预后模型。结果采用受试者工作特征(ROC)曲线和主成分分析(PCA)评估模型的预测性能,并通过校准曲线、nomogram和单变量/多变量Cox分析进一步验证模型的预测性能。除了功能富集分析外,还研究了模型与肿瘤突变负荷(Tumor Mutation Burden, TMB)、免疫细胞浸润和药物敏感性之间的关系。结论我们建立了一个由6个drlncrna组成的预测HNSCC患者预后的新模型,并从双翘角度提出了潜在的临床治疗靶点。证据等级:5级。
{"title":"Disulfidptosis ‒ related lncRNAs are biomarkers of prognosis and immune response in Head and Neck Squamous Cell Carcinoma","authors":"Ruilin Wang ,&nbsp;Qi Zhang ,&nbsp;Yuxiu Ma ,&nbsp;Xuelin Liu ,&nbsp;Tian Lan ,&nbsp;Hongling Li","doi":"10.1016/j.bjorl.2025.101625","DOIUrl":"10.1016/j.bjorl.2025.101625","url":null,"abstract":"<div><h3>Objective</h3><div>This study aims to explore the role of Disulfidptosis-Related long Non-Coding RNAs (DRlncRNAs) in the prognosis and immune infiltration of Head and Neck Squamous Cell Carcinoma (HNSCC).</div></div><div><h3>Methods</h3><div>Using bioinformatics approaches, this study investigates the prognostic significance of DRlncRNAs in HNSCC patients and their potential association with the immune microenvironment. RNA sequencing data and clinical information for HNSCC were obtained from The Cancer Genome Atlas (TCGA) database. DRlncRNAs were identified through Pearson correlation analysis, and a prognostic model consisting of six DRlncRNAs was constructed using Least Absolute Shrinkage and Selection Operator (LASSO) regression, along with univariate and multivariate Cox analyses.</div></div><div><h3>Results</h3><div>The predictive performance of the model was assessed using Receiver Operating Characteristic (ROC) curves and Principal Component Analysis (PCA), and further validated using calibration curves, a nomogram, and univariate/multivariate Cox analyses. In addition to functional enrichment analysis, the associations between the model and Tumor Mutation Burden (TMB), immune cell infiltration, and drug sensitivity were also examined.</div></div><div><h3>Conclusion</h3><div>We developed a novel predictive model composed of six DRlncRNAs to predict the prognosis of HNSCC patients and proposed potential clinical therapeutic targets from the perspective of disulfidptosis.</div></div><div><h3>Level of evidence</h3><div>Level 5.</div></div>","PeriodicalId":49099,"journal":{"name":"Brazilian Journal of Otorhinolaryngology","volume":"91 5","pages":"Article 101625"},"PeriodicalIF":1.7,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143947914","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Morphometric evaluation of cerebral and cerebellar structures in long-term unilateral sensorineural hearing loss 长期单侧感音神经性听力损失的大脑和小脑结构形态计量学评价
IF 1.7 4区 医学 Q2 OTORHINOLARYNGOLOGY Pub Date : 2025-09-01 Epub Date: 2025-05-08 DOI: 10.1016/j.bjorl.2025.101635
Gözde Orhan Kubat , Özkan Özen , Emre Çolak

Objective

Structural changes in the brain have been identified in patients with hearing loss. However, the effect of long-term Unilateral Sensorineural Hearing Loss (USNHL) on cerebral and cerebellar morphology is not fully understood.

Methods

In this study, Magnetic Resonance Imaging (MRI) of 12 long-term USNHL adults was compared with their Normal-Hearing (NH) side using Voxel-Based Morphometry (VBM). The USNHL group was also compared to a control group of 12 hearing-healthy individuals. Volume and cortical thickness changes in cerebral and cerebellar structures, possibly related to hearing loss severity and duration, were assessed using VBM.

Results

The study found that, compared to the control group, USNHL patients had significantly higher measurements in the Frontal Operculum (FO) Gray Matter (GM) volume (cm3) (p = 0.024), Superior Temporal Gyrus (STG) thickness (p = 0.041), and cerebellum IX GM volume (cm3) (p = 0.025). No significant differences were observed between the intact and NH sides in the USNHL group (p > 0.05).

Conclusion

Cerebral and cerebellar structures, which are essential for perceiving and interpreting sound, integrating information, and coordinating movement, may undergo morphological changes due to neuroadaptive mechanisms in long-term USNHL patients. Larger case series are needed to explore the clinical implications of these changes for diagnosis, treatment, and prognosis.

Levels of evidence

Level 3.
目的研究听力损失患者的大脑结构变化。然而,长期单侧感音神经性听力损失(USNHL)对大脑和小脑形态的影响尚不完全清楚。方法采用体素形态测量法(VBM)对12例长期USNHL成人的磁共振成像(MRI)与正常听力(NH)侧进行比较。USNHL组还与由12名听力健康个体组成的对照组进行了比较。使用VBM评估可能与听力损失严重程度和持续时间有关的大脑和小脑结构的体积和皮质厚度变化。结果研究发现,与对照组相比,USNHL患者额盖(FO)灰质(GM)体积(cm3) (p = 0.024)、颞上回(STG)厚度(p = 0.041)和小脑IX GM体积(cm3) (p = 0.025)均显著高于对照组。在USNHL组中,完整侧和非完整侧之间没有显著差异(p >;0.05)。结论长期USNHL患者的大脑和小脑结构在声音感知和解释、信息整合和运动协调中起着至关重要的作用,可能由于神经适应机制而发生形态学改变。需要更大的病例系列来探索这些变化对诊断、治疗和预后的临床意义。证据等级:3级。
{"title":"Morphometric evaluation of cerebral and cerebellar structures in long-term unilateral sensorineural hearing loss","authors":"Gözde Orhan Kubat ,&nbsp;Özkan Özen ,&nbsp;Emre Çolak","doi":"10.1016/j.bjorl.2025.101635","DOIUrl":"10.1016/j.bjorl.2025.101635","url":null,"abstract":"<div><h3>Objective</h3><div>Structural changes in the brain have been identified in patients with hearing loss. However, the effect of long-term Unilateral Sensorineural Hearing Loss (USNHL) on cerebral and cerebellar morphology is not fully understood.</div></div><div><h3>Methods</h3><div>In this study, Magnetic Resonance Imaging (MRI) of 12 long-term USNHL adults was compared with their Normal-Hearing (NH) side using Voxel-Based Morphometry (VBM). The USNHL group was also compared to a control group of 12 hearing-healthy individuals. Volume and cortical thickness changes in cerebral and cerebellar structures, possibly related to hearing loss severity and duration, were assessed using VBM.</div></div><div><h3>Results</h3><div>The study found that, compared to the control group, USNHL patients had significantly higher measurements in the Frontal Operculum (FO) Gray Matter (GM) volume (cm<sup>3</sup>) (<em>p</em> = 0.024), Superior Temporal Gyrus (STG) thickness (<em>p</em> = 0.041), and cerebellum IX GM volume (cm<sup>3</sup>) (<em>p</em> = 0.025). No significant differences were observed between the intact and NH sides in the USNHL group (<em>p</em> &gt; 0.05).</div></div><div><h3>Conclusion</h3><div>Cerebral and cerebellar structures, which are essential for perceiving and interpreting sound, integrating information, and coordinating movement, may undergo morphological changes due to neuroadaptive mechanisms in long-term USNHL patients. Larger case series are needed to explore the clinical implications of these changes for diagnosis, treatment, and prognosis.</div></div><div><h3>Levels of evidence</h3><div>Level 3.</div></div>","PeriodicalId":49099,"journal":{"name":"Brazilian Journal of Otorhinolaryngology","volume":"91 5","pages":"Article 101635"},"PeriodicalIF":1.7,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143924143","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A novel and effective surgical procedure for posterior nasal neurectomy in patients with allergic rhinitis 一种新颖有效的鼻后神经切除术治疗变应性鼻炎
IF 1.7 4区 医学 Q2 OTORHINOLARYNGOLOGY Pub Date : 2025-09-01 Epub Date: 2025-05-27 DOI: 10.1016/j.bjorl.2025.101653
Weini Hu , Qiang Zuo , Dawei Wu , Yu Song

Objective

This study aims to analyze how to perform a more minimally invasive and precise excision of posterior nasal neurectomy to reduce surgical time, minimize surgical trauma, and evaluate the clinical efficacy of this procedure in the treatment of moderate to severe persistent allergic rhinitis.

Methods

This study included a total of 110 patients, randomly divided into an experimental group and a control group based on whether preoperative CT three-dimensional positioning was used and whether middle turbinate mucosal graftcoverage was applied during surgery. In the experimental group, preoperative CT measurements were used to locate the sphenopalatine foramen, and intraoperatively, the accuracy of the positioning method was verified. Middle turbinate mucosal graftcoverage was applied to shorten the postoperative recovery time. Both groups were evaluated using Visual Analog Scales (VAS) and Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ) to compare the differences in symptoms between baseline and six months after operation. Regular endoscopic examinations were conducted to observe the status of mucosal epithelialization at the surgical site.

Results

Preoperative CT measurements provided accurate intraoperative localization of the sphenopalatine foramen, allowing for a smaller surgical wound size. The average distance from the sphenopalatine foramen to the posteroinferior end of the uncinate process was 20.25 ± 2.69 mm, and from the sphenopalatine foramen to the upper edge of the inferior turbinate, it was 11.05 ± 1.71 mm. There was no statistically significant difference in preoperative symptom scores between the two groups (p > 0.05). At six months after operation, there were significant differences in VAS scores compared to baseline in both the experimental and control groups (p < 0.05). The average time for mucosal graftsurvival in the experimental group was 3.5 ± 1.0 weeks, while in the control group, the average time for exposed bone surface epithelialization was 9.0 ± 1.5 weeks.

Conclusion

Preoperative CT measurements for locating the sphenopalatine foramen and the use of middle turbinate mucosal grafts in the posterior nasal neurectomy are safe and effective. This new procedure reduces surgical wound size, shorten surgical time, accelerate postoperative wound recovery, and could possibly reduce complications of bleeding after surgery.

Level of evidence

Level 3.
目的分析如何进行更微创、更精确的鼻后神经切除术,减少手术时间,减少手术创伤,并评价该手术治疗中重度持续性变应性鼻炎的临床疗效。方法本研究共纳入110例患者,根据术前是否使用CT三维定位,术中是否应用中鼻甲粘膜移植覆盖,随机分为实验组和对照组。实验组术前采用CT测量定位蝶腭孔,术中验证定位方法的准确性。应用中鼻甲黏膜覆盖,缩短术后恢复时间。采用视觉模拟量表(VAS)和鼻结膜炎生活质量问卷(RQLQ)对两组患者进行评估,比较基线和术后6个月症状的差异。定期进行内镜检查,观察手术部位粘膜上皮化情况。结果术中CT测量提供了蝶腭孔的准确定位,允许更小的手术伤口大小。蝶腭孔至钩突后下端平均距离为20.25±2.69 mm,蝶腭孔至下鼻甲上缘平均距离为11.05±1.71 mm。两组术前症状评分比较,差异无统计学意义(p > 0.05)。术后6个月,实验组和对照组的VAS评分与基线比较,差异均有统计学意义(p < 0.05)。实验组的平均存活时间为3.5±1.0周,对照组的平均骨表面上皮化时间为9.0±1.5周。结论术前CT定位蝶腭孔及应用中鼻甲粘膜移植物行鼻后神经切除术安全有效。这种新方法减小了手术伤口的大小,缩短了手术时间,加速了术后伤口的恢复,并可能减少手术后出血的并发症。证据等级:3级。
{"title":"A novel and effective surgical procedure for posterior nasal neurectomy in patients with allergic rhinitis","authors":"Weini Hu ,&nbsp;Qiang Zuo ,&nbsp;Dawei Wu ,&nbsp;Yu Song","doi":"10.1016/j.bjorl.2025.101653","DOIUrl":"10.1016/j.bjorl.2025.101653","url":null,"abstract":"<div><h3>Objective</h3><div>This study aims to analyze how to perform a more minimally invasive and precise excision of posterior nasal neurectomy to reduce surgical time, minimize surgical trauma, and evaluate the clinical efficacy of this procedure in the treatment of moderate to severe persistent allergic rhinitis.</div></div><div><h3>Methods</h3><div>This study included a total of 110 patients, randomly divided into an experimental group and a control group based on whether preoperative CT three-dimensional positioning was used and whether middle turbinate mucosal graftcoverage was applied during surgery. In the experimental group, preoperative CT measurements were used to locate the sphenopalatine foramen, and intraoperatively, the accuracy of the positioning method was verified. Middle turbinate mucosal graftcoverage was applied to shorten the postoperative recovery time. Both groups were evaluated using Visual Analog Scales (VAS) and Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ) to compare the differences in symptoms between baseline and six months after operation. Regular endoscopic examinations were conducted to observe the status of mucosal epithelialization at the surgical site.</div></div><div><h3>Results</h3><div>Preoperative CT measurements provided accurate intraoperative localization of the sphenopalatine foramen, allowing for a smaller surgical wound size. The average distance from the sphenopalatine foramen to the posteroinferior end of the uncinate process was 20.25 ± 2.69 mm, and from the sphenopalatine foramen to the upper edge of the inferior turbinate, it was 11.05 ± 1.71 mm. There was no statistically significant difference in preoperative symptom scores between the two groups (<em>p</em> &gt; 0.05). At six months after operation, there were significant differences in VAS scores compared to baseline in both the experimental and control groups (<em>p</em> &lt; 0.05). The average time for mucosal graftsurvival in the experimental group was 3.5 ± 1.0 weeks, while in the control group, the average time for exposed bone surface epithelialization was 9.0 ± 1.5 weeks.</div></div><div><h3>Conclusion</h3><div>Preoperative CT measurements for locating the sphenopalatine foramen and the use of middle turbinate mucosal grafts in the posterior nasal neurectomy are safe and effective. This new procedure reduces surgical wound size, shorten surgical time, accelerate postoperative wound recovery, and could possibly reduce complications of bleeding after surgery.</div></div><div><h3>Level of evidence</h3><div>Level 3.</div></div>","PeriodicalId":49099,"journal":{"name":"Brazilian Journal of Otorhinolaryngology","volume":"91 5","pages":"Article 101653"},"PeriodicalIF":1.7,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144138858","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Trends and future directions in chronic rhinosinusitis with nasal polyps: A bibliometric analysis 慢性鼻窦炎合并鼻息肉的趋势和未来方向:文献计量学分析
IF 1.7 4区 医学 Q2 OTORHINOLARYNGOLOGY Pub Date : 2025-09-01 Epub Date: 2025-07-03 DOI: 10.1016/j.bjorl.2025.101672
Yeming Zhong , Xuan Wei , Caiyun Zou , Bo Qian , Hongbo Ji , Jinhe Guo , Zigang Che

Objectives

Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) is a complex inflammatory condition that significantly impairs patients’ quality of life. Despite significant efforts to develop effective treatments, a comprehensive bibliometric analysis in this field is lacking. This study aims to identify key trends, influential publications, leading authors, and collaborative networks.

Methods

A bibliometric analysis was conducted on October 16, 2024, examining publications in the Web of Science Core Collection (WoSCC) database from 2004 to 2024. Data visualization and interpretation were performed using VOSviewer (version 1.6.20), CiteSpace (version 6.3.R1), and R 4.3.3.

Results

The analysis included 1,235 publications from 5,825 authors across 4,723 institutions in 222 countries. The United States led in publication volume, followed by China and Italy. Major institutional contributors included Capital Medical University and Sanofi. The International Forum of Allergy & Rhinology published the most articles, while the Journal of Allergy and Clinical Immunology had the highest citation count. Key authors identified were Bachert Claus and Gevaert Philippe. Keyword analysis revealed “asthma”, “endoscopic sinus surgery”, and “inflammation” as dominant themes, with burst analysis indicating growing interest in “humanization”, “type 2 inflammation”, “risk”, “biologics”, and “safety”.

Conclusion

This bibliometric analysis underscores an increasing focus on biologic therapies, inflammation management, and endoscopic sinus surgery in CRSwNP research. Future investigations are likely to prioritize the long-term safety and cost-effectiveness of biologics, alongside advancements in precision medicine and surgical techniques.

Level of evidence

Level 1.
慢性鼻窦炎伴鼻息肉(CRSwNP)是一种复杂的炎症性疾病,严重影响患者的生活质量。尽管为开发有效的治疗方法做出了重大努力,但在这一领域缺乏全面的文献计量分析。本研究旨在确定关键趋势、有影响力的出版物、主要作者和合作网络。方法于2024年10月16日对Web of Science Core Collection (WoSCC)数据库2004 - 2024年的出版物进行文献计量分析。使用VOSviewer(版本1.6.20)、CiteSpace(版本6.3.R1)和r4.3.3进行数据可视化和解译。该分析包括来自222个国家4723个机构的5825位作者的1235篇出版物。美国的出版物数量最多,其次是中国和意大利。主要机构捐助者包括首都医科大学和赛诺菲。国际过敏论坛;鼻科学发表的文章最多,而过敏和临床免疫学杂志的引用数最高。确定的主要作者是Bachert Claus和Gevaert Philippe。关键词分析显示,“哮喘”、“内窥镜鼻窦手术”和“炎症”是主要的主题,而突发分析显示,人们对“人性化”、“2型炎症”、“风险”、“生物制剂”和“安全性”的兴趣越来越大。该文献计量学分析强调了CRSwNP研究中对生物治疗、炎症管理和内窥镜鼻窦手术的日益关注。未来的研究可能会优先考虑生物制剂的长期安全性和成本效益,以及精准医学和外科技术的进步。证据等级:1级。
{"title":"Trends and future directions in chronic rhinosinusitis with nasal polyps: A bibliometric analysis","authors":"Yeming Zhong ,&nbsp;Xuan Wei ,&nbsp;Caiyun Zou ,&nbsp;Bo Qian ,&nbsp;Hongbo Ji ,&nbsp;Jinhe Guo ,&nbsp;Zigang Che","doi":"10.1016/j.bjorl.2025.101672","DOIUrl":"10.1016/j.bjorl.2025.101672","url":null,"abstract":"<div><h3>Objectives</h3><div>Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) is a complex inflammatory condition that significantly impairs patients’ quality of life. Despite significant efforts to develop effective treatments, a comprehensive bibliometric analysis in this field is lacking. This study aims to identify key trends, influential publications, leading authors, and collaborative networks.</div></div><div><h3>Methods</h3><div>A bibliometric analysis was conducted on October 16, 2024, examining publications in the Web of Science Core Collection (WoSCC) database from 2004 to 2024. Data visualization and interpretation were performed using VOSviewer (version 1.6.20), CiteSpace (version 6.3.R1), and R 4.3.3.</div></div><div><h3>Results</h3><div>The analysis included 1,235 publications from 5,825 authors across 4,723 institutions in 222 countries. The United States led in publication volume, followed by China and Italy. Major institutional contributors included Capital Medical University and Sanofi. The International Forum of Allergy &amp; Rhinology published the most articles, while the Journal of Allergy and Clinical Immunology had the highest citation count. Key authors identified were Bachert Claus and Gevaert Philippe. Keyword analysis revealed “asthma”, “endoscopic sinus surgery”, and “inflammation” as dominant themes, with burst analysis indicating growing interest in “humanization”, “type 2 inflammation”, “risk”, “biologics”, and “safety”.</div></div><div><h3>Conclusion</h3><div>This bibliometric analysis underscores an increasing focus on biologic therapies, inflammation management, and endoscopic sinus surgery in CRSwNP research. Future investigations are likely to prioritize the long-term safety and cost-effectiveness of biologics, alongside advancements in precision medicine and surgical techniques.</div></div><div><h3>Level of evidence</h3><div>Level 1.</div></div>","PeriodicalId":49099,"journal":{"name":"Brazilian Journal of Otorhinolaryngology","volume":"91 5","pages":"Article 101672"},"PeriodicalIF":1.7,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144549388","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Outcomes in patients with head and neck squamous cell carcinoma with exclusively surgical resection 单纯手术切除头颈部鳞状细胞癌患者的预后
IF 1.7 4区 医学 Q2 OTORHINOLARYNGOLOGY Pub Date : 2025-09-01 Epub Date: 2025-05-03 DOI: 10.1016/j.bjorl.2025.101622
Daniel Naves Araujo Teixeira , Fabio Lau , Vanessa Carvalho de Oliveira , Eduardo Vieira Couto , Thomas Peter Maahs , Carmen Silvia Passos Lima , Carlos Takahiro Chone

Objectives

To estimate patients’ overall and disease-free survival with squamous cell carcinoma of the oral cavity, oropharynx, and larynx, and assess the influence of primary local staging and histopathological features on these outcomes.

Methods

Retrospective data analysis of 102 patients with head and neck squamous cell carcinoma who underwent exclusive surgery as the initial treatment modality. p16 analysis was not evaluated. Exclusion criteria included patients with synchronous or metachronous tumors, those undergoing adjuvant or neoadjuvant chemotherapy or radiotherapy, and those with prior surgery at the exact site. Univariate and multivariate Cox Regression analyses were performed to evaluate outcome-related factors. Survival curves were estimated using the Kaplan-Meier method.

Results

The majority presented early stage I and II (83.4%), T1/T2 tumors (86.2%), N0 (95.1%), and all M0. The primary sites were mainly the larynx (46.1%) and oral cavity (41.2%). The mean overall survival was 71.76 months, with survival rates at 1-, 2-, 3-, 4-, and 5-years of 95.9%, 88.2%, 85.5%, 80.4%, and 74.7%, respectively. The mean disease-free survival was 68.2 months, with rates at 1-, 2-, 3-, 4-, and 5-years of 87.5%, 85.1%, 82.2%, 76.6%, and 69.3%, respectively. Active smoking was associated with a higher risk of death (HR = 9.4, p <  0.001) and recurrence (HR = 9.7, p <  0.001). Active smoking patients with perineural invasion presented worse overall and disease-free survival. Positive margins were associated with reduced disease-free survival.

Conclusion

Exclusive surgery in the early stages (I and II) emerges as a practical approach. Stage, primary site, margins, perineural invasion, lymphovascular invasion, and smoking cessation were the significant prognostic factors that affected patient outcomes.

Level of evidence

2C.
目的评估口腔、口咽部和喉部鳞状细胞癌患者的总生存率和无病生存率,并评估原发性局部分期和组织病理学特征对这些结果的影响。方法回顾性分析102例头颈部鳞状细胞癌患者首发手术治疗的资料。未评价P16分析。排除标准包括同步或异时性肿瘤患者,接受辅助或新辅助化疗或放疗的患者,以及在确切部位进行过手术的患者。采用单因素和多因素Cox回归分析评价结果相关因素。使用Kaplan-Meier法估计生存曲线。结果以早期I、II期肿瘤(83.4%)、T1/T2期肿瘤(86.2%)、N0期肿瘤(95.1%)为主,均为M0期肿瘤。原发部位主要为喉部(46.1%)和口腔(41.2%)。平均总生存期为71.76个月,1年、2年、3年、4年和5年生存率分别为95.9%、88.2%、85.5%、80.4%和74.7%。平均无病生存期为68.2个月,1年、2年、3年、4年和5年生存率分别为87.5%、85.1%、82.2%、76.6%和69.3%。积极吸烟与较高的死亡风险(HR = 9.4, p < 0.001)和复发率(HR = 9.7, p < 0.001)相关。伴有神经周围侵犯的吸烟患者总体生存率和无病生存率较差。切缘阳性与无病生存率降低相关。结论早期(ⅰ期和ⅱ期)单纯手术是一种可行的治疗方法。分期、原发部位、边缘、神经周围浸润、淋巴血管浸润和戒烟是影响患者预后的重要预后因素。证据水平2c。
{"title":"Outcomes in patients with head and neck squamous cell carcinoma with exclusively surgical resection","authors":"Daniel Naves Araujo Teixeira ,&nbsp;Fabio Lau ,&nbsp;Vanessa Carvalho de Oliveira ,&nbsp;Eduardo Vieira Couto ,&nbsp;Thomas Peter Maahs ,&nbsp;Carmen Silvia Passos Lima ,&nbsp;Carlos Takahiro Chone","doi":"10.1016/j.bjorl.2025.101622","DOIUrl":"10.1016/j.bjorl.2025.101622","url":null,"abstract":"<div><h3>Objectives</h3><div>To estimate patients’ overall and disease-free survival with squamous cell carcinoma of the oral cavity, oropharynx, and larynx, and assess the influence of primary local staging and histopathological features on these outcomes.</div></div><div><h3>Methods</h3><div>Retrospective data analysis of 102 patients with head and neck squamous cell carcinoma who underwent exclusive surgery as the initial treatment modality. p16 analysis was not evaluated. Exclusion criteria included patients with synchronous or metachronous tumors, those undergoing adjuvant or neoadjuvant chemotherapy or radiotherapy, and those with prior surgery at the exact site. Univariate and multivariate Cox Regression analyses were performed to evaluate outcome-related factors. Survival curves were estimated using the Kaplan-Meier method.</div></div><div><h3>Results</h3><div>The majority presented early stage I and II (83.4%), T1/T2 tumors (86.2%), N0 (95.1%), and all M0. The primary sites were mainly the larynx (46.1%) and oral cavity (41.2%). The mean overall survival was 71.76 months, with survival rates at 1-, 2-, 3-, 4-, and 5-years of 95.9%, 88.2%, 85.5%, 80.4%, and 74.7%, respectively. The mean disease-free survival was 68.2 months, with rates at 1-, 2-, 3-, 4-, and 5-years of 87.5%, 85.1%, 82.2%, 76.6%, and 69.3%, respectively. Active smoking was associated with a higher risk of death (HR = 9.4, <em>p</em> &lt;  0.001) and recurrence (HR = 9.7, <em>p</em> &lt;  0.001). Active smoking patients with perineural invasion presented worse overall and disease-free survival. Positive margins were associated with reduced disease-free survival.</div></div><div><h3>Conclusion</h3><div>Exclusive surgery in the early stages (I and II) emerges as a practical approach. Stage, primary site, margins, perineural invasion, lymphovascular invasion, and smoking cessation were the significant prognostic factors that affected patient outcomes.</div></div><div><h3>Level of evidence</h3><div>2C.</div></div>","PeriodicalId":49099,"journal":{"name":"Brazilian Journal of Otorhinolaryngology","volume":"91 5","pages":"Article 101622"},"PeriodicalIF":1.7,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143899367","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Voice symptoms, dysphagia risk, quality of life, and mental health in total laryngectomized patients: a self-perception study 喉全切除术患者的声音症状、吞咽困难风险、生活质量和心理健康:一项自我感知研究
IF 1.7 4区 医学 Q2 OTORHINOLARYNGOLOGY Pub Date : 2025-09-01 Epub Date: 2025-06-25 DOI: 10.1016/j.bjorl.2025.101657
João Vitor Barbosa Pereira , Vaneli Colombo Rossi , Carlos Takahiro Chone , Ana Carolina Constantini

Objectives

To establish the sociodemographic profile, identify and relate the presence of voice symptoms, risk for dysphagia, and self-perceived emotional distress, and measure the quality of life of a group of total laryngectomized patients.

Method

This is a descriptive, quantitative, cross-sectional study. Subjects aged 18-years and older, of both sexes, who had undergone total laryngectomy. The sample composition was non-probabilistic. A questionnaire was used to obtain sociodemographic data. The perception of voice symptoms was assessed by the Voice Symptom Scale (VoiSS) and the risk of dysphagia was screened using the Eating Assessment Tool (EAT-10). Mental health aspects were measured using the Self-Reporting Questionnaire (SRQ-20) and data on general health, treatment and illness were collected using the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core-30 (EORTC QLQ-C30).

Results

12 participants were recruited; mostly male, average age of 64-years. All participants presented voice symptoms and 33% were screened with self-perceived emotional distress and 66.7% progressed with risk for dysphagia; all of them had undergone at least radiotherapy during the treatment.

Conclusion

All subjects in the sample had voice symptoms. Risk of dysphagia emerged as a determining factor in the quality of life and mental health of study participants, and was also related to concomitant voice symptoms. In this sample, participants with a high prevalence of voice signs and symptoms were at greater risk of emotional distress.
目的建立全喉切除术患者的社会人口学特征,识别嗓音症状、吞咽困难风险和自我感觉情绪困扰的存在并将其联系起来,并测量其生活质量。方法采用描述性、定量、横断面研究。受试者年龄在18岁及以上,男女皆可,接受过全喉切除术。样本组成是非概率的。采用问卷调查的方式获取社会人口统计数据。通过语音症状量表(VoiSS)评估对声音症状的感知,并使用进食评估工具(EAT-10)筛选吞咽困难的风险。心理健康方面使用自我报告问卷(SRQ-20)进行测量,一般健康、治疗和疾病数据使用欧洲癌症研究和治疗组织生活质量问卷Core-30 (EORTC QLQ-C30)收集。结果共招募12名受试者;以男性为主,平均年龄64岁。所有的参与者都有声音症状,33%的人有自我感觉的情绪困扰,66.7%的人有吞咽困难的风险;所有患者在治疗期间都至少接受过放疗。结论所有被试均有声音症状。吞咽困难的风险成为研究参与者生活质量和心理健康的决定性因素,也与伴随的声音症状有关。在这个样本中,声音体征和症状高发的参与者有更大的情绪困扰风险。
{"title":"Voice symptoms, dysphagia risk, quality of life, and mental health in total laryngectomized patients: a self-perception study","authors":"João Vitor Barbosa Pereira ,&nbsp;Vaneli Colombo Rossi ,&nbsp;Carlos Takahiro Chone ,&nbsp;Ana Carolina Constantini","doi":"10.1016/j.bjorl.2025.101657","DOIUrl":"10.1016/j.bjorl.2025.101657","url":null,"abstract":"<div><h3>Objectives</h3><div>To establish the sociodemographic profile, identify and relate the presence of voice symptoms, risk for dysphagia, and self-perceived emotional distress, and measure the quality of life of a group of total laryngectomized patients.</div></div><div><h3>Method</h3><div>This is a descriptive, quantitative, cross-sectional study. Subjects aged 18-years and older, of both sexes, who had undergone total laryngectomy. The sample composition was non-probabilistic. A questionnaire was used to obtain sociodemographic data. The perception of voice symptoms was assessed by the Voice Symptom Scale (VoiSS) and the risk of dysphagia was screened using the Eating Assessment Tool (EAT-10). Mental health aspects were measured using the Self-Reporting Questionnaire (SRQ-20) and data on general health, treatment and illness were collected using the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core-30 (EORTC QLQ-C30).</div></div><div><h3>Results</h3><div>12 participants were recruited; mostly male, average age of 64-years. All participants presented voice symptoms and 33% were screened with self-perceived emotional distress and 66.7% progressed with risk for dysphagia; all of them had undergone at least radiotherapy during the treatment.</div></div><div><h3>Conclusion</h3><div>All subjects in the sample had voice symptoms. Risk of dysphagia emerged as a determining factor in the quality of life and mental health of study participants, and was also related to concomitant voice symptoms. In this sample, participants with a high prevalence of voice signs and symptoms were at greater risk of emotional distress.</div></div>","PeriodicalId":49099,"journal":{"name":"Brazilian Journal of Otorhinolaryngology","volume":"91 5","pages":"Article 101657"},"PeriodicalIF":1.7,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144472318","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Long-term efficacy and safety of different biologics in treatment of chronic rhinosinusitis with nasal polyps: A network meta-analysis 不同生物制剂治疗慢性鼻窦炎合并鼻息肉的长期疗效和安全性:一项网络meta分析
IF 1.7 4区 医学 Q2 OTORHINOLARYNGOLOGY Pub Date : 2025-07-01 Epub Date: 2025-04-25 DOI: 10.1016/j.bjorl.2025.101633
Han Chen , Lin Wang , Jisheng Zhang, Xudong Yan, Longgang Yu, Yan Jiang

Objectives

Direct comparison of the long-term effectiveness and safety of biologics for Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) is lacking. The study aimed to compare the long-term efficacy and safety of various biologics in the management of CRSwNP.

Methods

The PubMed, Embase, Cochrane Library, and Web of Science databases were searched from database inception to March 2024, to identify all relevant literature on the use of biologics for CRSwNP. The research protocol was registered on PROSPERO.Two independent reviewers screened the studies, extracted the data, and performed a quality assessment using the Cochrane Risk of Bias tool. Network meta-analysis was conducted using STATA 17.0 and Review Manager (Version 5.3).

Results

Six studies with a minimum follow-up period of 52-weeks were analyzed, demonstrating the superior long-term efficacy of dupilumab compared to the other three biologics. The surface under the cumulative ranking curve were 100% for Nasal Polyp Score (NPS), 72.7% for Sino-Nasal Outcome Test-22 (SNOT-22), 94.6% for Visual Analogue Scale (VAS), and 100% for Nasal Congestion Score (NCS). In the comparison of NPS, dupilumab showed improvements of 1.84 (95% Confidence Interval [95% CI 0.78, 2.91]) over mepolizumab and 2.31 (95% CI 0.99, 3.63) over benralizumab. Among the symptom scores evaluated, only dupilumab achieved a significant improvement in NCS compared to benralizumab, with an improvement of 0.74 (95% CI 0.86, 1.19). No significant differences in adverse events was observed between biologics treatment or versus placebo.

Conclusion

Treatment with dupilumab in patients with CRSwNP has shown superior long-term efficacy in reducing NPS and various symptom scores compared to other biologics. However, the results should be interpreted with caution due to the heterogeneity of patient characteristics across the included studies (e.g., disease severity, history of surgery, use of oral corticosteroids).
目的缺乏生物制剂治疗慢性鼻窦炎合并鼻息肉(CRSwNP)的长期疗效和安全性的直接比较。本研究旨在比较各种生物制剂治疗CRSwNP的长期疗效和安全性。方法检索PubMed、Embase、Cochrane Library和Web of Science数据库,检索自建库至2024年3月的所有生物制剂用于CRSwNP的相关文献。研究方案已在PROSPERO上注册。两名独立审稿人筛选研究,提取数据,并使用Cochrane偏倚风险工具进行质量评估。使用STATA 17.0和Review Manager (Version 5.3)进行网络meta分析。结果对6项最短随访期为52周的研究进行了分析,表明与其他三种生物制剂相比,dupilumab具有优越的长期疗效。鼻息肉评分(NPS)为100%,鼻-鼻结局测试-22 (SNOT-22)为72.7%,视觉模拟量表(VAS)为94.6%,鼻塞评分(NCS)为100%。在NPS的比较中,dupilumab比mepolizumab改善1.84(95%可信区间[95% CI 0.78, 2.91]),比benralizumab改善2.31 (95% CI 0.99, 3.63)。在评估的症状评分中,与贝那利单抗相比,只有dupilumab在NCS方面取得了显著改善,改善幅度为0.74 (95% CI 0.86, 1.19)。在不良事件方面,生物制剂治疗组与安慰剂组没有显著差异。结论与其他生物制剂相比,dupilumab治疗CRSwNP患者在降低NPS和各种症状评分方面具有更优越的长期疗效。然而,由于纳入研究的患者特征存在异质性(例如,疾病严重程度、手术史、口服皮质类固醇的使用),因此对结果的解释应谨慎。
{"title":"Long-term efficacy and safety of different biologics in treatment of chronic rhinosinusitis with nasal polyps: A network meta-analysis","authors":"Han Chen ,&nbsp;Lin Wang ,&nbsp;Jisheng Zhang,&nbsp;Xudong Yan,&nbsp;Longgang Yu,&nbsp;Yan Jiang","doi":"10.1016/j.bjorl.2025.101633","DOIUrl":"10.1016/j.bjorl.2025.101633","url":null,"abstract":"<div><h3>Objectives</h3><div>Direct comparison of the long-term effectiveness and safety of biologics for Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) is lacking. The study aimed to compare the long-term efficacy and safety of various biologics in the management of CRSwNP.</div></div><div><h3>Methods</h3><div>The PubMed, Embase, Cochrane Library, and Web of Science databases were searched from database inception to March 2024, to identify all relevant literature on the use of biologics for CRSwNP. The research protocol was registered on PROSPERO.Two independent reviewers screened the studies, extracted the data, and performed a quality assessment using the Cochrane Risk of Bias tool. Network meta-analysis was conducted using STATA 17.0 and Review Manager (Version 5.3).</div></div><div><h3>Results</h3><div>Six studies with a minimum follow-up period of 52-weeks were analyzed, demonstrating the superior long-term efficacy of dupilumab compared to the other three biologics. The surface under the cumulative ranking curve were 100% for Nasal Polyp Score (NPS), 72.7% for Sino-Nasal Outcome Test-22 (SNOT-22), 94.6% for Visual Analogue Scale (VAS), and 100% for Nasal Congestion Score (NCS). In the comparison of NPS, dupilumab showed improvements of 1.84 (95% Confidence Interval [95% CI 0.78, 2.91]) over mepolizumab and 2.31 (95% CI 0.99, 3.63) over benralizumab. Among the symptom scores evaluated, only dupilumab achieved a significant improvement in NCS compared to benralizumab, with an improvement of 0.74 (95% CI 0.86, 1.19). No significant differences in adverse events was observed between biologics treatment or versus placebo.</div></div><div><h3>Conclusion</h3><div>Treatment with dupilumab in patients with CRSwNP has shown superior long-term efficacy in reducing NPS and various symptom scores compared to other biologics. However, the results should be interpreted with caution due to the heterogeneity of patient characteristics across the included studies (e.g., disease severity, history of surgery, use of oral corticosteroids).</div></div>","PeriodicalId":49099,"journal":{"name":"Brazilian Journal of Otorhinolaryngology","volume":"91 4","pages":"Article 101633"},"PeriodicalIF":1.7,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143874544","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Identification of key hub genes and potential therapeutic drugs for nasopharyngeal carcinoma: Insights into molecular mechanisms and treatment strategies 识别鼻咽癌的关键枢纽基因和潜在治疗药物:洞察分子机制和治疗策略
IF 1.7 4区 医学 Q2 OTORHINOLARYNGOLOGY Pub Date : 2025-07-01 Epub Date: 2025-04-25 DOI: 10.1016/j.bjorl.2025.101618
Haiyan Quan , Hongguo Yin , Zhen Wang , Yuan Lv , Qiong Sun , Ting Yin

Objective

Nasopharyngeal Carcinoma (NPC) is a highly malignant cancer with a high incidence in East and Southeast Asia, including southern China. Despite advances in treatment, the prognosis for advanced NPC remains poor due to high recurrence and metastasis rates. The molecular mechanisms driving NPC progression are not fully understood, and identifying key genes and potential therapeutic agents is critical. This study aims to uncover critical genes and screen therapeutic drugs, providing insights into NPC pathogenesis and novel treatment strategies.

Methods

Three GEO datasets (GSE12452, GSE53819, and GSE61218) were analyzed to identify overlapping Differentially Expressed Genes (DEGs) in NPC. Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG), and Gene Set Enrichment Analysis (GSEA) were used to explore the biological roles of DEGs. Protein-Protein Interaction (PPI) and mRNA-miRNA-lncRNA interaction networks were constructed to identify key hub genes. Potential therapeutic drugs were predicted via a Drug-Gene Interaction network. The overexpression of hub genes was validated in NPC cells using CCK-8 assays, and the anti-proliferative effects of three drugs ‒ valproic acid, cyclosporine, and calcitriol ‒ were tested.

Results

Eight hub genes (ASPM, BIRC5, BUB1B, CDK1, KIF23, PBK, TOP2A, and TTK) were identified, with ASPM reported for the first time in the context of NPC. Overexpression of these genes significantly promoted NPC cell proliferation. Among the tested drugs, calcitriol exhibited the most potent anti-proliferative effect, with IC50 values of 0.90 μM, 0.47 μM, and 0.31 μM at 24-, 48-, and 72-hs, respectively.

Conclusion

This study identified eight key genes as potential biomarkers for NPC and validated calcitriol as a promising therapeutic agent, providing a foundation for further research into NPC treatment.

Level of evidence

Level 2 (Individual cross-sectional studies or systematic review of surveys that allow matching to local circumstances).
目的鼻咽癌(NPC)是一种高度恶性的癌症,在包括中国南部在内的东亚和东南亚地区发病率很高。尽管治疗手段不断进步,但由于复发率和转移率较高,晚期鼻咽癌的预后仍然很差。驱动鼻咽癌进展的分子机制尚未完全明了,因此确定关键基因和潜在治疗药物至关重要。本研究旨在发现关键基因并筛选治疗药物,为了解鼻咽癌的发病机制和新型治疗策略提供依据。方法分析了三个 GEO 数据集(GSE12452、GSE53819 和 GSE61218),以确定鼻咽癌中重叠的差异表达基因(DEGs)。基因本体(GO)、京都基因和基因组百科全书(KEGG)和基因组富集分析(GSEA)被用来探索 DEGs 的生物学作用。构建了蛋白质-蛋白质相互作用(PPI)和mRNA-miRNA-lncRNA相互作用网络,以确定关键枢纽基因。通过药物-基因相互作用网络预测潜在的治疗药物。结果确定了八个中心基因(ASPM、BIRC5、BUB1B、CDK1、KIF23、PBK、TOP2A 和 TTK),其中 ASPM 是首次在鼻咽癌中被报道。这些基因的过表达能明显促进鼻咽癌细胞的增殖。在所测试的药物中,钙三醇的抗增殖作用最强,在24、48和72小时的IC50值分别为0.90 μM、0.47 μM和0.31 μM。结论本研究发现了作为鼻咽癌潜在生物标志物的八个关键基因,并验证了钙三醇是一种有前景的治疗药物,为进一步研究鼻咽癌的治疗提供了基础。
{"title":"Identification of key hub genes and potential therapeutic drugs for nasopharyngeal carcinoma: Insights into molecular mechanisms and treatment strategies","authors":"Haiyan Quan ,&nbsp;Hongguo Yin ,&nbsp;Zhen Wang ,&nbsp;Yuan Lv ,&nbsp;Qiong Sun ,&nbsp;Ting Yin","doi":"10.1016/j.bjorl.2025.101618","DOIUrl":"10.1016/j.bjorl.2025.101618","url":null,"abstract":"<div><h3>Objective</h3><div>Nasopharyngeal Carcinoma (NPC) is a highly malignant cancer with a high incidence in East and Southeast Asia, including southern China. Despite advances in treatment, the prognosis for advanced NPC remains poor due to high recurrence and metastasis rates. The molecular mechanisms driving NPC progression are not fully understood, and identifying key genes and potential therapeutic agents is critical. This study aims to uncover critical genes and screen therapeutic drugs, providing insights into NPC pathogenesis and novel treatment strategies.</div></div><div><h3>Methods</h3><div>Three GEO datasets (GSE12452, GSE53819, and GSE61218) were analyzed to identify overlapping Differentially Expressed Genes (DEGs) in NPC. Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG), and Gene Set Enrichment Analysis (GSEA) were used to explore the biological roles of DEGs. Protein-Protein Interaction (PPI) and mRNA-miRNA-lncRNA interaction networks were constructed to identify key hub genes. Potential therapeutic drugs were predicted via a Drug-Gene Interaction network. The overexpression of hub genes was validated in NPC cells using CCK-8 assays, and the anti-proliferative effects of three drugs ‒ valproic acid, cyclosporine, and calcitriol ‒ were tested.</div></div><div><h3>Results</h3><div>Eight hub genes (ASPM, BIRC5, BUB1B, CDK1, KIF23, PBK, TOP2A, and TTK) were identified, with ASPM reported for the first time in the context of NPC. Overexpression of these genes significantly promoted NPC cell proliferation. Among the tested drugs, calcitriol exhibited the most potent anti-proliferative effect, with IC50 values of 0.90 μM, 0.47 μM, and 0.31 μM at 24-, 48-, and 72-hs, respectively.</div></div><div><h3>Conclusion</h3><div>This study identified eight key genes as potential biomarkers for NPC and validated calcitriol as a promising therapeutic agent, providing a foundation for further research into NPC treatment.</div></div><div><h3>Level of evidence</h3><div>Level 2 (Individual cross-sectional studies or systematic review of surveys that allow matching to local circumstances).</div></div>","PeriodicalId":49099,"journal":{"name":"Brazilian Journal of Otorhinolaryngology","volume":"91 4","pages":"Article 101618"},"PeriodicalIF":1.7,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143874624","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Brazilian Journal of Otorhinolaryngology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1